During the past decade, Parkside Pediatrics conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Parkside Pediatrics" are "Acute Respiratory Tract Infections" (1 trials), "Molluscum Contagiosum" (1 trials) and "Pneumococcal Infections" (1 trials). Many other conditions were trialed in "Parkside Pediatrics" in a lesser frequency.

Most popular intervention types in "Parkside Pediatrics" are "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "FebriDx" (1 trials), "Multivalent" (1 trials), "Prevnar 13" (1 trials), "VBP-245 Topical Gel" (1 trials) and "Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parkside Pediatrics" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Parkside Pediatrics". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Parkside Pediatrics, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Parkside Pediatrics, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".